Author: Mokhtar

  • Inadequate energy intake affects female athletes

    Inadequate energy intake affects female athletes

    A new study from Aarhus University shows that when female athletes decrease their energy intake and increase their training, their health and the ability of their muscles to respond to training are negatively affected.

    Diet and training go hand in hand if you want to achieve the best results. Most athletes know this, and many of them monitor their energy intake and training closely. However, a new study from the Department of Public Health at Aarhus University shows that the bodies of female athletes are negatively affected when the athletes consume too little energy through their diet compared to their training volume, explains PhD student Mikkel Oxfeldt. He and Associate Professor Mette Hansen are behind the research.

    “We know that both top female athletes and active women sometimes, consciously or unconsciously, do not have an energy intake that matches their energy expenditure during training. The research shows that insufficient energy intake can have a negative effect on the ability of the muscles to respond to After just ten days of low energy intake, we started to see changes in the hormonal system, such as a decrease in metabolic hormone , followed by a decrease in metabolism.’

    The research shows that it is important for women to be careful not to reduce their energy intake too much. In fact, they should actually increase their energy intake as they increase their training volume, says Mikkel Oxfeldt:

    “If you don’t get enough energy from your diet, your body starts to slow down processes that require a lot of energy, much like a cell phone going into battery-saving mode. We know from previous studies that this can lead to menstruation. However, our results show that other processes in the body, such as the build-up of new muscle proteins, are also affected.”

    We must confront the one-sided focus on weight

    Thirty fit women aged between 18 and 30 took part in the study, which is part of the Novo Nordic-funded Team Denmark network called ‘competition preparation and training optimization’. All women started the study immediately after the start of their period and followed a highly controlled exercise and diet regimen for three weeks.

    “Under the supervision of the researchers, the participants performed individual training programs aimed at increasing muscle mass, strength and overall fitness. We also provided the women’s meals. By monitoring their training regimen and their diet, we were able to see how much energy they expended and what they ate during the study,” says Mikkel Oxfeldt and continues:

    “This is the first time such a well-controlled study has been conducted in this area, with both the diet and exercise of a group of fit women regulated to this extent. During the study, all participants drank double-labeled water. “, which is enriched with trace material. When we combine this tracer technique with the retrieval and subsequent analysis of muscle tissue samples, we can gain detailed insight into the response of the muscles to the experimental protocol,” explains Mikkel Oxfeldt.

    Mikkel and the research group believe that it is necessary to confront the idea that weight loss leads to medals, when in fact weight loss can negatively impact a number of body systems, including the muscles.

    “In recent years we have heard about public weigh-ins within some elite sports. They are part of promoting a culture where some women are constantly trying to lose weight. However, our results show that this focus on weight loss can have negative consequences on the short and possibly long term for women, both in relation to their health and training results. The research will hopefully give athletes and coaches a more nuanced picture of possible side effects.”

    In collaboration with colleagues from the University of Copenhagen and the University of Southern Denmark, the researchers behind the study are now investigating how physical performance, the immune system and metabolism are affected by insufficient energy intake. They hope to one day be able to determine whether there is a difference between the way women’s and men’s bodies respond to insufficient energy intake.

    Source link

  • Headgear does not help prevent concussions in football and rugby athletes

    Headgear does not help prevent concussions in football and rugby athletes

    Does headgear prevent sports-related concussions? A systematic review and meta-analysis of randomized controlled trials involving 6311 players and 173,383 exposure hours.

    Al Attar WSA, Mahmoud H, Alfadel A, Faude O. Sports health. May 19, 2023: 19417381231174461. doi: 10.1177/19417381231174461. E-publishing prior to printing. PMID: 37204092.

    Full text not freely available

    Take home message

    Headgear worn by young football or rugby players cannot reduce the incidence of sports-related concussions.

    Background

    Protective headgear reduces the risk of facial and dental injuries; However, there is inconsistent research supporting the rate at which they prevent sports-related concussions.

    Study aim

    In this systematic review, the authors identified and summarized findings from three randomized control trials evaluating whether headgear effectively reduces the incidence of sports-related concussions.

    Methods

    The authors systematically searched five databases to identify randomized control trials that evaluated the extent to which headgear prevented sports-related concussions. All control groups wore no headgear. The authors recorded exposure hours and number of players to calculate injury rates and document compliance.

    Results

    The 3 studies had an ‘average’ to ‘good’ methodological quality on the PEDro scale. The primary outcome assessed in each study was the rate of sports-related concussions per group (headgear vs. no headgear/control). The aggregated results include 6,311 players and 173,383 exposure hours. The authors found that headgear did not prevent concussions in football or rugby. Compliance was variable between studies (99.6%, 46% and not measured in one study).

    Viewpoints

    The authors of this systematic review concluded that the risk of sports-related concussion was virtually identical in the group with or without headgear. It should be noted that the rugby trials exclusively involved young men. While the football trials involved women, the study focused on 14- to 16-year-olds. Therefore, it is unclear how headgear performs among older athletes and female rugby players. The authors also found that compliance was quite variable. One football study had high adherence, while one rugby study had low adherence. It would be useful to understand whether differences in compliance are related to different strategies to promote compliance, differences in sport, or personal preferences for headgear styles. Understanding what worked in football but not in rugby could help identify strategies to promote good compliance.

    Clinical implications

    Medical professionals should not promote the wearing of headgear for football and rugby athletes to prevent concussion. Instead, medical professionals should promote concussion education on what can prevent a concussion, such as proper form (e.g., keeping head up while dribbling/being aware of surroundings) and proper tackling technique in rugby (e.g., not using head). .

    Questions for discussion

    Do you encourage headgear in sports such as football and rugby? Does this systematic review change your position? Why or why not?

    related posts

    1. Headgear can reduce concussion risk in high school lacrosse
    2. Aftermarket helmet add-ons don’t add up
    3. Women are not only at increased risk for concussions, but also for more severe concussions
    4. A Closer Look at Concussions 2016-2020: Increasing Prevalence and Gender Differences

    Written by Jane McDevitt
    Reviewed by Jeffrey Driban

    Evidence-based assessment of concussion course - 5 EBP CEUs

    Source link

  • Anti-TNF-α therapy induced psoriasis in patients with rheumatoid arthritis according to FDA postmarketing surveillance data

    FDA Adverse Event Reporting System (FAERS)

    The United States Food and Drug Administration Adverse Event Reporting System (FAERS) is a data repository that collects voluntary drug-related reports from healthcare professionals, consumers, and legal representatives. In cases where the adverse reaction (AE) is reported to the manufacturer, the manufacturer is required to forward the report to FAERS. At the time of the survey, FAERS contained 17,392,666 AE reports collected from the first quarter of 2004 (including historical reports since 1982) through the second quarter of 2022. The reports are available online: https://www.fda.gov/ medications/questions-and-answers-fdas-reporting-system-faers-side-effects/fda-reporting-system-faers-last-quarter-data.

    Data preparation

    FAERS reports are added quarterly and stored in a set of text files. Subsets of data are organized by specific report fields (demographics, drug, side effects, outcome, etc.) and their respective case IDs. The data format is not uniform and has changed several times since its inception. Therefore, appropriate changes have been made. Moreover, as the side effect reports are collected from all over the world, the respective brand names of drugs are translated into the generic equivalents19,20,21.

    Study results

    The MedDRA Dictionary version 25.1 was searched to define the measured study outcomes using higher-level terms such as “immune-associated conditions not elsewhere classified (NEC)” and “psoriatic conditions.” All psoriasis-associated preferred terms (PT) were used in the search. To avoid indication-related confounding effects, psoriatic conditions associated with RA, such as psoriatic arthropathy, were excluded from the MedDRA PT list. The following PTs were used for the definition psoriasis in the analysis: erythrodermic psoriasis, guttate psoriasis, nail psoriasis, psoriasiform dermatitis, pustular psoriasis and psoriasis.

    Cohort selection

    Of the total 17,392,666 adverse event reports in FAERS, a total of 881,182 reports included RA indications, and for 663,922 of these, RA was listed as the sole indication. These data were further broken down by monotherapies and only reports from physicians, pharmacists and other healthcare professionals were included to avoid bias and increase clinical relevance. The final monoindication + monotherapy sets were as follows: certolizumab pegol (n = 5168), adalimumab (n = 9221), golimumab (n = 2899), tocilizumab (n = 4819), abatacept (n = 7574), infliximab (n = 5579), rituximab (n = 2519), etanercept (n = 89543), tofacitinib (n = 10686), and methotrexate (n = 6142). Demographic analysis was performed for TNF inhibitors and methotrexate RA AE cohorts (Tables 1 and 2). The following terms for psoriasis are included: erythrodermic psoriasis, guttate psoriasis, nail psoriasis, psoriasiform dermatitis, pustular psoriasis and psoriasis. These psoriasis type terms describe the psoriasis Adverse event rates were calculated for each drug cohort: certolizumab pegol (n = 98), adalimumab (n = 107), golimumab (n = 20), tocilizumab (n = 29), abatacept (n = 40), infliximab (n = 29 ), rituximab (n = 11), etanercept (n = 260), tofacitinib (n = 24), and methotrexate (n = 7). A disproportionality analysis was performed using the reported AE rates to calculate the reporting odds ratios (RORs). These figures were used to calculate psoriasis reported frequencies. Methotrexate was selected as a control cohort because of its unique mechanism of action (MOA) as an immunosuppressant that inhibits the conversion of folic acid to folic acid cofactors, and because of its common use as a monotherapy in RA.

    Demographic analysis

    Gender (Table 1).

    Table 1 The total number of reports of TNF inhibitors and methotrexate in the combined RA cohorts, separated by reported gender.

    Age (Table 2).

    Table 2 The total number of reports of TNF inhibitors and methotrexate in the combined RA cohorts, separated by reported age.

    static analysis

    Descriptive statistics

    The frequencies for each side effect examined (Figs. 1, 3) were calculated using the following equation:

    $$\textFrequency = \left( \textnReports\,\text with \,\textpsoriasis \,\textin \, \texta \,\textcohort \right)/\textnReports\,\text in \,\texta \,\ textcohort*100$$

    (1)

    Frequency error:

    $$\textError = \left( \sqrt \textnReports \,\textwith\, \textpsoriasis\,\text in \,\text a\, \textcohort \right)/\textnReports\,\text in\,\text a \,\textcohort*100$$

    (2)

    Comparative statistics

    The numbers of psoriasis reports were compared via the Reporting Odds Ratio (ROR) analysis for Fig. 2, 4 and 5 and Tables 3, 4 and 5 using the following equations:

    $$\mathrmROR=(\mathrma/\mathrmb)/(\mathrmc/\mathrmd)$$

    (3)

    where Number of cases in exposed group with psoriasis, Number of cases in exposed group without psoriasis, Number of cases in control group with psoriasis, Number of cases in control group without psoriasis.

    Table 3 RORs and 95% CIs were calculated based on comparisons between each TNF inhibitor monotherapy cohort and the methotrexate cohort.
    Table 4 RORs and 95% CIs were calculated based on comparisons between each monotherapy cohort examined and the methotrexate cohort.
    Table 5 RORs and 95% CIs were calculated based on comparisons between the certolizumab pegol monotherapy cohort and each of the other monotherapy cohorts studied.

    $$\mathrmLnROR=\mathrmLn(\mathrmROR)$$

    (4)

    Standard error of odds ratio for log reporting;

    $$\mathrmSE_\mathrmLnROR=\sqrt1/\mathrma+1/\mathrmb+1/\mathrmc+1/\mathrm d$$

    (5)

    95% confidence interval;

    $$95\text\%CI = \left[ {\textexp\left( \textLnROR – 1.96 \times \textSE_\textLnROR \right),\textexp\left( {\textLnROR + 1.96 \times \textSE_{\textLnROR} } \right)} \right]$$

    (6)

    Source link

  • ATEC announces closure of public share issue

    ATEC announces closure of public share issue

    CARLSBAD, California, October 27, 2023–(BUSINESS WIRE)–Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative solutions aimed at revolutionizing the approach to spine surgery, today announced the closing of its previously announced underwritten public offering of 14,300,000 shares of its common stock at a public offering price of $ 10.50 per share.

    Morgan Stanley, TD Cowen, Barclays and Stifel acted as joint book-running managers on the offering.

    ATEC received gross proceeds of $150,150,000 from the offering.

    The shares of common stock were offered pursuant to a registration statement on Form S-3 (File No. 333-271336) previously filed with and declared effective by the Securities and Exchange Commission (the “SEC”). The offering was made by means of a prospectus supplement and the accompanying prospectus. A preliminary prospectus supplement, a final prospectus supplement and a companion prospectus relating to the offering have previously been filed with the SEC and are available on the SEC’s website at www.sec.gov. The preliminary prospectus supplement, the final prospectus supplement and the accompanying base prospectus are available on the SEC’s website and may also be obtained from Morgan Stanley, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014; Cowen and Company, LLC, 599 Lexington Avenue, New York, New York 10022, by telephone at (833) 297-2926 or by email at prospectus_ecm@cowen.com; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by telephone at 1-888-603-5847 or by email at barclaysprospectus@broadridge.com.

    This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

    About ATEC

    ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging SAS and SafeOp Surgical, Inc., is a medical device company committed to revolutionizing the approach to spine surgery through clinical differentiation. ATEC’s Organic Innovation Machine™ is focused on developing new approaches that integrate seamlessly with the company’s growing AlphaInformatiX Platform to better inform surgery and achieve the goals of spine surgery more safely and reproducibly. ATEC’s vision is to be the standard bearer in the spine field.

    Contacts

    Company contact:
    J. Todd King
    Finance Director
    investorrelations@atecspine.com

    Investor/media contact:
    Tina Jacobsen, CFA
    Investor Relations
    (760) 494-6790
    investorrelations@atecspine.com

    Source link

  • Research suggests that children’s IQ is not reduced by concussion

    Research suggests that children’s IQ is not reduced by concussion

    The fear that parents feel when their children suffer injuries is undoubtedly one of the universal conditions of parenthood. That fear is greatly increased when those injuries involve concussions. But a new study from the University of Calgary, published today in the medical journal Pediatricscan provide some reassurance to concerned parents.

    The findings – from emergency room visits at children’s hospitals in Canada and the United States – show that IQ and intelligence are not affected in a clinically meaningful way by pediatric concussions.

    The study compares 566 children with concussions to 300 children with orthopedic injuries. The children range in age from eight to sixteen years and were recruited from two cohort studies. The Canadian cohort includes data collected from five children’s hospital emergency departments, including Alberta Children’s Hospital in Calgary, along with those in Vancouver, Edmonton, Ottawa and Montreal (CHU Sainte-Justine). In Canadian hospitals, patients completed IQ tests three months after injury.

    The US cohort was conducted at two children’s hospitals in Ohio, where patients completed IQ tests three to 18 days after injury.

    “There is clearly a lot of concern about the effects of concussion on children, and one of the biggest questions is whether or not it affects a child’s overall intellectual functioning,” says Dr. Keith Yeates, PhD, a professor at the University of Calgary. Psychology and senior author of the Pediatrics paper. Yeates is a renowned expert on the effects of brain disorders in children, including concussion and traumatic brain injury.

    “The data on this is mixed and opinions within the medical community vary,” says Yeates. “It is difficult to collect large enough samples to confirm a negative finding. The absence of a difference in IQ after a concussion is more difficult to prove than the presence of a difference.”

    Combining the Canadian and American cohorts yielded the Pediatrics studied an abundant sample and it allowed Yeates and his co-authors – from universities in Edmonton, Montreal, Vancouver, Ottawa, Atlanta, Utah and Ohio, along with Mount Royal University in Calgary – to study patients with a wide range of demographic characteristics to test and clinical characteristics.

    “We looked at the patient’s socio-economic status, gender, severity of injuries, history of concussion and whether there was loss of consciousness at the time of injury,” says Yeates. “None of these factors made a difference. Across the board, concussion was not associated with lower IQ.”

    The children with concussion were compared to children with orthopedic injuries other than concussion to control for other factors that might influence IQ, such as demographic background and the experience of trauma and pain. This allowed the researchers to determine whether the children’s IQs were different than expected, minus the concussion.

    The study’s findings are important to share with parents, says Dr. Ashley Ware, PhD, professor at Georgia State University and lead author of the paper. While the Pediatrics research was underway, Ware was a Killam Postdoctoral Fellow at UCalgary, where Yeates was her supervisor.

    “Understandably, there is a lot of fear among parents when it comes to their children’s concussions,” says Ware. “These new findings offer really good news, and we need to get the message across to parents.”

    Dr. The paper’s co-author Stephen Freedman, PhD, professor of pediatrics and emergency medicine at the Cumming School of Medicine, agrees. “It’s something doctors can tell children who have suffered a concussion, and their parents, to help reduce their fears and concerns,” says Freedman. “It is certainly reassuring to know that concussions do not lead to changes in IQ or intelligence.”

    Another power of the Pediatrics research is that includes the two cohort studies, one testing patients within days of their concussion and the other after three months.

    “That makes our claim even stronger,” says Ware. “We can show that even in the first days and weeks after a concussion, when children show symptoms such as pain and slow processing speed, their IQ is not affected. Then it’s the same story three months later, when most children have recovered.” This study allows us to say that we consistently do not expect IQ to decline from the time children are symptomatic to the time they have recovered.”

    She adds: “It’s a nice ‘rest in peace’ message for the parents.”

    Source link

  • Epidemiology and clinical features of interstitial lung disease in patients with rheumatoid arthritis from the JointMan database

    Data source

    Patient demographics and disease characteristics were retrospectively analyzed after data extraction from the Discus Analytics JointMan database, a large US electronic health record-based dataset initiated in March 2009. The JointMan database includes > 17,000 rheumatology patients covered by commercial, Medicare, or Medicaid insurance. plan. Practices in the following eight states are included: Washington, New York, Oregon, Florida, Georgia, California, Wisconsin and Kentucky. Patient data were collected in rheumatology centers and anonymized prior to analysis. In addition to electronic medical record data, the JointMan user interface collects clinical results recorded by physicians at the time of the encounter.

    Patient population

    Patients were included if they were ≥ 18 years old at first visit to a rheumatologist participating in the JointMan network, had a provider-selected diagnosis of RA between January 1, 2009 and September 20, 2019, and had ≥ 1 visit after the first visit. visit date. Patients were excluded if their first encounter occurred after RA diagnosis or if they experienced a drug-induced ILD diagnosis [International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) codes J70.2 and J70.4] at any time during the study period. Patients were assigned to the RA cohort (patients with confirmed RA but no diagnosis of ILD during the study period) or the RA-ILD cohort (patients with a diagnosis of unmedicated ILD on or after the initial diagnosis date of RA). ). The RA index date was defined as the first RA diagnosis date recorded in the JointMan database (provided by the rheumatologist).

    The total study population consisted of patients followed from the day after the RA index date until the patient’s last encounter date or the end of the study (September 20, 2019), whichever came first. RA was diagnosed according to the ICD, Ninth Revision, CM (ICD-9-CM) code 714.0 and ICD-10-CM codes M05 and M06. ILD was identified by ICD diagnosis codes (ICD-9-CM codes: 516.0, 516.2, 516.3, 516.4, 516.5, 516.8, and 516.9; ICD-10-CM codes: J84.0, J84.1, J84.2, J84 .81, J84.82, J84.83, J84.89 and J84.9) or as indicated by the provider.

    A subanalysis was performed on a series of patients grouped according to ILD diagnosis. For the subanalysis population, the ILD diagnosis index was defined as the first date of ILD diagnosis recorded in the JointMan database (for patients in the RA-ILD cohort), and patient characteristics were described for the 90-day periods before and after the ILD. diagnosis index. For patients without ILD, the index date was based on the distribution of the number of days between RA diagnosis and ILD diagnosis in the RA-ILD cohort; characteristics were described for the 90-day periods before and after the index date (Supplementary Figure S1).

    Primary endpoints

    The primary endpoints, assessed in the total study population, were the prevalence and time to onset of ILD. Prevalence was defined as the proportion of patients with RA and a diagnosis of ILD divided by the total number of patients with RA during the study period. Time to onset of ILD was defined as the time from the initial diagnosis of RA to the first observed non-drug ILD diagnosis.

    Exploratory endpoints

    Exploratory endpoints, assessed in the exploratory analysis population, included baseline demographics, comorbidities, RA characteristics, and overall RA disease activity in the RA cohort compared with the RA-ILD cohort. RA features include joint stiffness, erosions, extra-articular disease, anti-CCP antibodies, joint swelling, ESR, C-reactive protein (CRP), and Clinical Disease Activity Index (CDAI). The CDAI remission score was defined as ≤ 2.8; CDAI low, moderate, and high disease activity scores were defined as >2.8–10, >10–22, and >22, respectively19. The Simplified Disease Activity Index (SDAI) remission score was defined as ≤ 3.3; SDAI low, moderate, and high disease activity scores were defined as > 3.3 to 11, > 11 to 26, and > 26, respectively19. Disease activity score in 28 joints using CRP (DAS28 [CRP]) remission score was defined as ≤ 2.3; DAS28 (CRP) low, moderate and high disease activity scores were defined as > 2.3 to 2.7, > 2.7 to < 4.1 and ≥ 4.1, respectively20. DAS28 (ESR) remission score was defined as <2.6; DAS28 (ESR) low, moderate, and high disease activity scores were defined as 2.6 to 2.6, respectively < 3,2, 3,2–5,1 en > 5.1.19 Routine Assessment of Patient Index Data 3 (RAPID3) remission score was defined as ≤ 3; RAPID3 low, moderate, and high disease activity scores were defined as >3 to 6, >6 to 12, and >12, respectively21. Variables were assessed as potential predictors of RA-ILD.

    Subanalysis endpoints

    For patients included in the subanalysis population, CDAI and RAPID3 scores, number of swollen and swollen28 joints, number of encounters with rheumatologists, and treatment use before and after the ILD diagnosis index were also assessed. The number of swollen and swollen28 joints is part of the DAS/DAS28 score: the number of swollen joints is an assessment of 28 or more (maximum 44) joints, while the number of swollen28 joints is an assessment of only 28 pre-selected joints22.

    static analysis

    The prevalence (95% confidence intervals [CIs]) of the first observed ILD diagnosis during follow-up was calculated. Time to ILD diagnosis was examined using unadjusted Kaplan-Meier survival curves. Descriptive statistics for continuous baseline variables were compared using Student’s Ttest and percentages for categorical and binary basic variables were compared using the Chi-square test.

    Potential predictors of RA-ILD were analyzed with a Cox regression model. Patient demographics and comorbidities were collected at baseline and controlled in the Cox model. RA features were identified during and after initial RA diagnosis and were controlled as time-varying covariates in the Cox model. The final covariate lists were based on clinical rationale and model fit; Hazard Ratios, 95% Confidence Intervals, and P Values ​​were provided for each covariate. Statistical significance for model inclusion was set at P<0.05.

    The number and percentage of patients with visits to a rheumatologist, treatment utilization, and each disease activity score in the pre- and post-index periods were calculated. P-values ​​for the disease activity score category compared pre- and post-index periods and correspond to Fisher’s exact test or Chi-square test with statistical significance set at P<0.05.

    Ethical approval

    This study was conducted in accordance with the International Society for Pharmacoepidemiology Guidelines for Good Pharmacoepidemiology Practices and applicable regulatory requirements23. The study protocol was reviewed by the internal BMS Observational Protocol Review Committee (OPRC). No identifiable protected health information was retrieved from or accessed from the database during the study. Therefore, the BMS OPRC confirmed that this analysis did not require ethical oversight. In addition, the study did not involve the collection, use, or transmission of individually identifiable data, and the data was collected in the setting for the patient’s usual care. Informed consent from the study participants was not required because the dataset used in this observational study consisted of anonymized secondary data released for research purposes.

    Source link

  • Reducing hamstring injuries is at the heart of a good injury prevention program

    Reducing hamstring injuries is at the heart of a good injury prevention program

    Effectiveness of injury prevention programs with core muscle strengthening exercises to reduce the incidence of hamstring injuries in football players: a systematic review and meta-analysis.

    Al Attar WSA and Husain MA. Sports Health. 2023 [Epub Ahead of Print].

    Full text freely available

    Take home message

    Injury prevention programs with core muscle strengthening exercises reduce the risk of hamstring injuries in football players.

    Background

    Football players are at risk for many lower limb injuries, especially hamstring injuries. Many researchers have shown that injury prevention programs, which often include core muscle strengthening exercises, can reduce the risk of lower extremity injuries. However, it remains unclear whether injury prevention programs that include core muscle strengthening exercises effectively reduce the risk of hamstring injuries.

    Study aim

    The researchers completed a systematic review and meta-analysis to investigate whether an injury prevention program, including core strengthening exercises, reduces the number of hamstring injuries.

    Methods

    Researchers conducted an extensive literature review of randomized clinical trials involving (1) injury prevention training programs that included core strengthening exercises, (2) an outcome measure for the number of hamstring injuries, (3) a control comparison, and (4) football players of any type. level. Two researchers evaluated the risk of bias among the included studies.

    Results

    The authors analyzed five studies. One study was a randomized controlled trial, while the others were cluster randomized controlled trials. Each trial included 209 to 1,892 participants, for a total of 4,485 participants across all studies. Participants completed the injury prevention programs for 10 weeks to 8 months and had compliance rates ranging from 21% to 91%. Three of the five studies were considered to be at low risk of bias. Across all studies, 171 hamstring injuries were recorded during 379,102 exposures. Overall, completing an injury prevention training program that included core strengthening exercises (e.g. FIFA 11+) resulted in a 47% reduction in hamstring injuries compared to the control group (typically a standard warm-up program).

    Viewpoints

    Overall, this study supports the implementation of an injury prevention program involving core muscle strengthening exercises to reduce the risk of hamstring injuries in football players. Although this finding is useful to many physicians, gaps remain. For example, the low number of studies that met the inclusion criteria limits our confidence in the results. For example, although we estimate that these prevention programs reduce the risk of hamstring injuries by 47%, we can only be confident that the actual risk reduction likely ranges from 2% to 72%. More studies and a larger sample size would help us better understand how effective these programs are in reducing the risk of hamstring injuries. The studies also did not use identical interventions. While this may frustrate some people because we can’t say we have to do this specific program, it can also reassure us that we may have some flexibility to customize programs for each team and still experience the benefits. Ultimately, injury prevention programs that include core strengthening exercises are low risk and low cost and can help reduce the risk of injuries, especially hamstring injuries.

    Clinical implications

    Clinicians should encourage football teams to use injury prevention training programs that include core muscle strengthening exercises. These programs are often low riskcheapand completed in less than 15 minutes.

    Questions for discussion

    What do you look for when evaluating injury prevention programs for implementation? Have you specifically looked for core strengthening in the past? Why or why not?

    Written by Kyle Harris
    Reviewed by Jeffrey Driban

    related posts

    Exercises that target specific hamstring muscle groups
    Clinical Findings Triumph baseline MRI findings in predicting hamstring re-injury shortly after return to play
    Another feather in the cap of the FIFA 11+ Injury Prevention Program
    FIFA 11+ reduces the risk of injuries for football players

    9 EBP CEU courses

    Source link

  • Early Warning Report – Acquisition of Aurora Spine Corporation Stock

    Early Warning Report – Acquisition of Aurora Spine Corporation Stock

    Toronto, Ontario, October 27, 2023 (GLOBE NEWSWIRE) — David Rosenkrantz (“Acquiror”) announces that he has filed an early warning report under National Instrument 62-103 in connection with the acquisition of 2,250,000 voting common shares (“Shares”) and 2,250,000 Share Purchase Warrants (“Warrants”) from Aurora Spine Corporation (the “Company”) for an aggregate amount of CAD$675,000.

    On October 19, 2023, the acquirer acquired Shares and Warrants of the Company pursuant to a private placement (the “Private Placement”), which in total resulted in the cumulative acquisition of more than 2% of the outstanding Shares of the Company. , which creates the requirement to submit an early warning report. Immediately prior to the acquisition, the Acquiring party owned 9,625,000 Shares of the Company. The 9,625,000 Shares represented approximately 13.56% of the total number of Shares issued and outstanding prior to the Private Placement. As a result of the acquisition, the Acquirer now beneficially owns 11,875,000 Shares of the Company, which is equal to 15.34% of the outstanding Shares of the Company, resulting in a change of 1.78% in the Acquirer’s share ownership side. If all Warrants were converted, the Acquirer would, directly or indirectly, own or exercise control or direction of approximately 17.73% of the total number of issued and outstanding Shares, which would result in an increase of 4.17% of Share Ownership of the Acquirer on a partially diluted basis.

    Although the Acquirer currently has no plans or intentions with respect to the Company’s Shares, depending on market conditions, general economic and industry conditions, trading prices of the Company’s Shares, the Company’s business, financial condition and prospects and/or other relevant factors, The acquirer may develop such plans or intentions in the future and may from time to time acquire additional Shares, dispose of some or all existing or additional Shares or sell the Shares of the Company keep holding.

    A copy of the acquirer’s early warning report filing will be available on Aurora Spine Corporation’s SEDAR+ profile at www.sedarplus.ca. The Company’s registered office is located at 1930 Palomar Point Way, Suite 103, Carlsbad, California, 92008 and the acquirer’s address is at Patica Corporation, The Exchange Tower, 130 King St. W., Suite 2210, Toronto, Ontario, M5X 1E4 .

    Aurora Spine Corporation

    760-424-2004

    Source link

  • Why you should turn to physical therapy first

    Why you should turn to physical therapy first

    Through Mike Basten PT, DPT, MTC

    Over the past two decades, more and more states have provided patients with pain with direct access to physical therapy without a physician referral. Although the state of Arizona has offered this type of access for several years, insurance companies have only recently begun paying for physical therapy without a doctor’s referral. Direct access is just one of many reasons why you should look into physical therapy first. There are many more.

    There is increasing data showing that seeing a physical therapist first can reduce costs and improve the overall outcome of injury rehabilitation. The American Physical Therapy Association (APTA) just published a groundbreaking study: The economic value of physical therapy in the United States,’ confirming that physical therapy (PT) can help Americans live better lives while saving the healthcare system millions of dollars annually.

    Historically, the process from injury to recovery has involved seeing a doctor, trying medications, receiving diagnostic imaging, resting, and hoping for a resolution. If the problem was not resolved, the next step was to try physical therapy and perhaps some type of medical intervention such as injections or surgery. However, due to the rising costs of medical care, insurance companies and patients have started looking for methods to reduce the costs of rehabilitation. One of these methods is to first try PT for musculoskeletal problems.

    Top three reasons to seek PT for pain first

    1. Reduce or eliminate pain without drugs or opioids.

    Physiotherapy offers the opportunity to reduce or eliminate pain through specific therapeutic exercises and hands-on manual therapy techniques. Additional treatments such as ultrasound, electrical stimulation, and taping techniques can also reduce pain during recovery.

    Physiotherapy has come a long way in the past 20 to 25 years, as have the patients it helps. Due to costs and other factors, the goal now is to solve the problem as quickly as possible with as little use of health care as possible. PT allows the therapist to treat the cause of the pain early and begin rehabilitation by restoring the correct mechanisms that may be causing the pain.

    A 2018 study analyzed 200,000 commercial and Medicare Advantage insurance beneficiaries seeking treatment for low back pain. It found that those who were initially referred by a physical therapist, chiropractor, or acupuncturist, compared to those who had an index visit by a primary care provider, reduced the likelihood of early opioid use by 85%-91% and long-term opioid use by 73% reduced. %-78%.

    Physical therapy can provide a pain management alternative to opioid use.

    2. Savings on diagnostics

    Being able to go straight to physiotherapy is cost-effective. For example, a patient avoids paying to see a doctor for a referral, and the doctor may order expensive diagnostic tests before determining that PT is the appropriate treatment method. A qualified therapist will work to avoid unnecessary diagnostics during your recovery, which can increase out-of-pocket costs and affect your long-term well-being. They will also work with your doctor to explore pre-surgery, post-surgery, and non-surgery options for a full recovery.

    If physical therapy can address the reasons contributing to the pain, in many cases you can avoid surgery altogether. If you do need surgery, preoperative physical therapy can improve mobility and strength and help you get into better shape, allowing you to recover from surgery faster and with better results more easily with postoperative physical therapy.

    When we look at patients who went to physical therapy first, there was an average savings of over $250 in one study and over $1,000 in another. Overall, there were significant savings across the board with less imaging, less medication, and even less treatment.

    FH Injury Prevention Blog 1 1

    3. Improve mobility.

    If you have difficulty standing, walking, or with transitions, such as moving from a sitting to a standing position, exercises to improve flexibility and strength can improve your ability to move more easily, making daily activities more enjoyable. Physical therapists can help you identify areas where you’re not moving correctly, predisposing you to future injuries, and correcting those movements to keep you injury-free. A PT can also instruct and fit you for an assistive device such as a cane, crutches, or other aids designed to improve your mobility.

    PTs are also trained to recognize when physical therapy is needed not the correct or best first course of action and can point patients in the best direction. The physician-PT team is still the standard in treating musculoskeletal problems and guiding people with pain to a full recovery.

    The search for full recovery is a journey without shortcuts and without a finish line. A journey that will lead to astonishing and satisfying results. At Foothills Sports Medicine Physical Therapy, our therapists embrace the journey. We take you, your pain and your full recovery seriously and do not believe that a good enough recovery is good enough. We strive to do everything we can to help you regain your full, healthy life.

    If you have questions about immediate access to physical therapy, contact the Foothills Sports Medicine Physical Therapy clinic nearest you and schedule a free pain assessment.

    Source link

  • A new review calls on Hockey Canada to raise the age for body contact from 13 to 15

    A new review calls on Hockey Canada to raise the age for body contact from 13 to 15

    Hockey leagues in Canada should revise current rules and regulations to raise the age for body checking in the game from 13 to 15, says new research into the effect of body contact on teens.

    The literature search was led by Dr. Kristian Goulet of the University of Ottawa’s Faculty of Medicine and the Children’s Hospital of Eastern Ontario (CHEO) calls on provincial and territorial governments to mandate schools – including those involved in school sports – and sports organizations to establish policies and protocols set, update and enforce to prevent concussions, with a sharp emphasis on body contact.

    Currently, hockey organizations in Canada allow body contact in competitive and recreational leagues from the age of 13. But studies have shown that when body contact is initiated, injuries increase significantly, including concussions.

    Nearly half of hockey injuries are caused by body checks, with injury rates four times higher for children and teens in leagues where body checks are allowed. Other studies have shown that concussions are reduced by more than 50% when body contact is eliminated. An estimated 200,000 concussions occur in Canada each year, mainly affecting children and youth. Ice hockey is the leading cause of all sports and recreation-related brain injuries in pediatric age groups, in both boys and girls.

    Dr. Goulet is hopeful that this review will prompt Hockey Canada to forge a new path forward to strengthen our understanding of concussion and guidance for clinical management, especially as it relates to acute care, ongoing symptoms and prevention.

    “Sports are incredibly important to the mental, physical, emotional and social health of our children. However, it is our duty as caregivers, parents, coaches, administrators and decision makers that we make every reasonable effort to make sports as safe as possible,” says Dr. Goulet, an assistant professor at the Ottawa School of Medicine and the medical director of the CHEO Concussion Clinic, the Eastern Ontario Concussion Clinic and the Pediatric Sports Medicine Clinic of Ottawa.

    Source link